- Melatonin is not a fat-loss supplement. No well-powered human trial has shown meaningful body-fat reduction from melatonin supplementation alone.
- Melatonin may support metabolic health indirectly by improving sleep quality — poor sleep is a well-established driver of weight gain (Spiegel et al., 2004).
- Animal studies show intriguing effects on brown adipose tissue and insulin sensitivity, but these findings have not translated convincingly to humans.
- If your goal is fat loss, fixing disrupted sleep may help, but taking melatonin as a "metabolism booster" is not supported by current evidence.
What the evidence shows
Melatonin is best known as a circadian-rhythm regulator and sleep aid. The question of whether it also burns fat comes mostly from two streams of research: animal studies and a small number of short human trials — neither of which builds a strong case for supplementation as a fat-loss strategy.
On the animal side, researchers have found that melatonin supplementation in rodents increases the proportion of beige/brown adipose tissue, reduces visceral fat accumulation, and improves insulin sensitivity (Jiménez-Aranda et al., 2013). These are legitimately interesting findings. The problem is that rodent physiology — especially around adipose tissue and circadian biology — differs substantially from humans, and rodent results routinely fail to replicate in clinical trials.
In humans, the picture is much thinner. A 2016 randomized controlled trial in postmenopausal women (Amstrup et al., 2016) found that 1 mg/day of melatonin over 12 months produced a modest reduction in fat mass (about 7% relative to placebo) alongside a small increase in lean mass. This is the most-cited human study supporting a direct effect, but it was a relatively small trial (81 participants), conducted in a hormonally specific population (postmenopausal women, who have lower endogenous melatonin), and the absolute changes were minor. It has not been replicated at scale.
Outside of that one trial, the evidence in healthy adults or people with obesity is not compelling. A 2021 systematic review examining melatonin and metabolic outcomes concluded that while melatonin may modestly improve insulin sensitivity and lipid profiles in people with metabolic syndrome, direct evidence for fat-mass reduction in humans remains limited and inconsistent (Hosseinzadeh et al., 2021).
The more credible pathway melatonin might help with weight is through sleep. Chronic short sleep (under 7 hours) increases ghrelin, suppresses leptin, elevates cortisol, and reduces insulin sensitivity — all of which favor fat gain and muscle loss (Spiegel et al., 2004; Taheri et al., 2004). If melatonin helps someone with insomnia or circadian disruption achieve better sleep, the downstream metabolic benefits are real. But that is a sleep intervention, not a fat-loss one. If your sleep is already adequate, adding melatonin does little.
How it works (mechanism)
Melatonin is produced by the pineal gland in response to darkness and binds to MT1 and MT2 receptors throughout the body, including in adipose tissue and the pancreas. Proposed mechanisms for any metabolic effect include:
- Circadian entrainment: Melatonin helps synchronize peripheral clocks in metabolic tissues. Circadian misalignment is independently associated with insulin resistance and increased fat storage (Scheer et al., 2009).
- Brown adipose tissue activation: Animal studies suggest melatonin upregulates UCP1 (the "uncoupling protein" that generates heat rather than ATP) in brown and beige fat, increasing thermogenesis (Jiménez-Aranda et al., 2013). Human evidence for this pathway is lacking.
- Antioxidant and anti-inflammatory action: Melatonin is a potent antioxidant and may reduce low-grade inflammation, which is elevated in obesity. Whether this translates to meaningful fat loss is unproven.
- Insulin secretion modulation: MT1 receptors in pancreatic beta cells inhibit insulin secretion during the night — appropriate timing of melatonin exposure may support healthier diurnal insulin patterns.
These mechanisms are plausible but largely theoretical or demonstrated only in animal models when it comes to direct fat loss in humans.
Dose & timing if you try it
If you have documented sleep difficulties — trouble falling asleep, jet lag, or shift-work disruption — and want to address the sleep-metabolism link, the evidence-based approach to melatonin is:
- Dose: 0.5–1 mg is effective for most sleep purposes; higher doses (3–10 mg) are widely sold but are not more effective for sleep and may cause next-day grogginess. The Amstrup et al. (2016) fat-mass trial used 1 mg/day.
- Timing: 30–60 minutes before intended sleep, in a dark environment. Taking it at inconsistent times undermines the circadian effect.
- Duration: Short-term use (days to a few weeks) for circadian shifting is well-supported. Long-term use beyond a few months has less established safety data in healthy adults.
Do not expect melatonin to meaningfully accelerate fat loss on its own. Pair it with consistent sleep timing, adequate duration (7–9 hours for adults), and a caloric deficit supported by diet and activity — which are the evidence-based foundations of fat loss.
Who should skip
- Pregnant or breastfeeding individuals: Safety data are insufficient; avoid without explicit medical supervision.
- Children and adolescents: Melatonin affects hormonal development; use only under a clinician's guidance.
- People on anticoagulants (e.g., warfarin): Melatonin may potentiate blood-thinning effects.
- People on immunosuppressants: Melatonin has immune-modulating properties that may interfere.
- People with autoimmune conditions: Theoretical concern about immune stimulation.
- Anyone taking sedatives or CNS depressants: Additive sedation is possible.
- Anyone hoping for direct fat loss without addressing diet, sleep, or activity: The evidence does not support this use.
Bottom line
Melatonin is not a fat-loss supplement by any reasonable reading of the current evidence. One small RCT in postmenopausal women hints at a modest effect on body composition, but it stands largely alone. The more defensible role for melatonin in the weight-management context is as a sleep-support tool: if poor or misaligned sleep is undermining your metabolism and recovery, addressing it with low-dose melatonin (alongside good sleep hygiene) is a reasonable step. But melatonin is not moving the needle on the scale directly — your sleep quality, diet, and activity level are.
Verdict: Skip melatonin as a fat-loss supplement. Consider it only if disrupted sleep is a documented problem, and treat it as a sleep intervention, not a weight-loss one.
References
- Amstrup, A. K., Sikjaer, T., Mosekilde, L., & Rejnmark, L. (2016). The effect of melatonin treatment on postmenopausal women: a pilot study. Hormone and Metabolic Research, 48(11), 714–722.
- Hosseinzadeh, A., Kamrava, S. K., Joghataei, M. T., et al. (2021). Melatonin and metabolic syndrome: a systematic review. Melatonin Research, 4(1), 44–63.
- Jiménez-Aranda, A., Fernández-Vázquez, G., Campos, D., et al. (2013). Melatonin induces browning of inguinal white adipose tissue in Zucker diabetic fatty rats. Journal of Pineal Research, 55(4), 416–423.
- Scheer, F. A., Hilton, M. F., Mantzoros, C. S., & Shea, S. A. (2009). Adverse metabolic and cardiovascular consequences of circadian misalignment. Proceedings of the National Academy of Sciences, 106(11), 4453–4458.
- Spiegel, K., Tasali, E., Penev, P., & Van Cauter, E. (2004). Brief communication: Sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite. Annals of Internal Medicine, 141(11), 846–850.
- Taheri, S., Lin, L., Austin, D., Young, T., & Mignot, E. (2004). Short sleep duration is associated with reduced leptin, elevated ghrelin, and increased body mass index. PLOS Medicine, 1(3), e62.